Addressing Challenges in Myeloid Cancers with Advanced Genomic Profiling
Myeloid malignancies, including acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN), are complex diseases driven by genetic alterations. Understanding these mutations is crucial for accurate diagnosis, prognosis, and therapeutic decisions. The Uncoded Myeloid Profiler DNA Panel is a powerful tool designed to detect critical genomic variations in myeloid cancers, providing high-resolution insights for researchers and clinicians.
Product Overview
The Uncoded Myeloid Profiler DNA Panel is a next-generation sequencing (NGS) solution developed to analyze 75 genes associated with myeloid malignancies. Using advanced target enrichment and high-depth sequencing, this panel ensures comprehensive coverage of both DNA hotspot regions and full coding sequence (CDS) regions of key genes.